title: [The significance of the erythrocyte antioxidant system in the development of anemia in hemoblastosis patients].
authors.forename: V I
authors.initials: VI
authors.lastname: Petukhov
authors.forename: E
authors.initials: E
authors.lastname: Iansons
authors.forename: D K
authors.initials: DK
authors.lastname: Bondare
authors.forename: A
authors.initials: A
authors.lastname: Toma
authors.forename: A
authors.initials: A
authors.lastname: Shkesteris
authors.forename: A
authors.initials: A
authors.lastname: Kumerova
authors.forename: V L
authors.initials: VL
authors.lastname: Rastrigin
authors.forename: A V
authors.initials: AV
authors.lastname: Demidova
mesh_terms: D000328:Adult; D000368:Aged; D000740:Anemia / Q000097:blood / Q000188:drug therapy / Q000209:etiology*; D000975:Antioxidants; D004359:Drug Therapy, Combination; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007938:Leukemia / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D015227:Lipid Peroxidation / Q000187:drug effects; D008297:Male; D008315:Malondialdehyde / Q000097:blood; D008875:Middle Aged; D013482:Superoxide Dismutase / Q000097:blood / Q000187:drug effects
chemical_list: D000975:Antioxidants; D008315:Malondialdehyde; D013482:Superoxide Dismutase
vernacular_title: O znachenii antioksidantnoĭ sistemy éritrotsitov v razvitii anemii u bol'nykh gemoblastozami.